Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population

被引:0
作者
Yunpeng Chi
Conghong Shi
Xiaojiang Zhang
Yang Xi
机构
[1] Capital Medical University,Department of 21A Ward, Beijing Anzhen Hospital
[2] Baotou Fourth Hospital,Department of Cardiology
[3] Capital Medical University,Department of 21B Ward, Beijing Anzhen Hospital
[4] Inner Mongolia Medical University,Department of Human Anatomy, College of Basic Medicine
来源
Journal of Thrombosis and Thrombolysis | 2018年 / 46卷
关键词
PLA2G7; Coronary heart disease; SNP; Interaction; Smoking; Drinking; Haplotype;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate the impact of PLA2G7 polymorphism, and additional their interactions with smoking and drinking on coronary heart disease (CHD) risk based on Chinese population. GMDR model was used to screen the best gene–smoking and gene–drinking interaction combinations. Logistic regression was performed to investigate association between 4 SNPs and CHD, and the interaction effect between rs1805017 and smoking. For CHD patient–control haplotype analyses, the SHEsis online haplotype analysis software (http://analysis.bio-x.cn/myAnalysis.php) was employed. CHD risks were higher in carriers of homozygous mutant of rs1805017 and rs1805018 than those with wild-type homozygotes, OR (95% CI) were 1.45 (1.16–1.92) and 1.51 (1.23–1.97), respectively, but the other two SNPs, rs16874954 and rs1051931 were not significant associated with CHD risks. GMDR analysis indicated that there was a significant two-locus model (p = 0.0107) involving rs1805017 and smoking, indicating a potential gene–environment interaction between rs1805017 and smoking. But we did not found any gene–drinking and gene–gene interaction combinations in GMDR models. The haplotype R-I was observed most frequently in two groups, with 47.43 and 54.38% in the case and control group of the population, respectively. The results also indicated that the haplotype containing the rs1805017-H and rs1805018-T alleles were associated with a statistically increased CHD risk, OR (95% CI) 1.43 (1.10–1.86), p = 0.0021. Polymorphisms in rs1805017 and rs1805018, additional interaction between rs1805017 and smoking, and haplotype containing the rs1805017-H and rs1805018-T alleles were associated with increased CHD risk.
引用
收藏
页码:125 / 130
页数:5
相关论文
共 213 条
  • [1] Lopez AD(2006)Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 1747-1757
  • [2] Mathers CD(2015)Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skovde Cohort BMC Cardiovasc Disord 15 146-602.e1
  • [3] Ezzati M(2014)National trend in congenital heart disease mortality in china during 2003 to 2010: a population-based study J Thorac Cardiovasc Surg 148 596-2271
  • [4] Jamison DT(2015)Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials Lancet 385 2264-1046
  • [5] Murray CJ(1994)Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1041-229
  • [6] Daka B(2012)Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy Lancet 380 219-138
  • [7] Olausson J(2013)Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments Int J Cardiol 168 132-22
  • [8] Larsson CA(2012)Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease Lipids Health Dis 11 55-50F
  • [9] Hellgren MI(2002)Lp-PLA2: an emerging biomarker of coronary heart disease Expert Rev Mol Diagn 2 17-750
  • [10] Råstam L(2008)Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker Am J Cardiol 101 41F-1028